GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a major focus in therapeutic research, largely due to its impressive impact on managing ailments such as type 2 diabetes and obesity. Recent trials have revealed that more than glucose management, GLP-1 agonists offer benefits for circulatory well-being and even cognitive co